L Bjermer
Overview
Explore the profile of L Bjermer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
1695
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fokkens W, Backer V, Lund V, Barnes P, Bernal-Sprekelsen M, Bjermer L, et al.
Rhinology
. 2025 Mar;
PMID: 40042485
The introduction of biologics for the treatment of severe upper and lower (type 2) airway inflammation has been a gamechanger in the management of these diseases. Biologics are injectable medications...
2.
Fokkens W, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, von Buchwald C, et al.
Rhinology
. 2024 Jan;
62(3):287-298.
PMID: 38217529
Severe chronic rhinosinusitis with nasal polyps (CRSwNP), a form of diffuse bilateral (usually type 2) CRS, is a debilitating disease with a significant impact on quality of life (QoL). With...
3.
Roth-Walter F, Adcock I, Benito-Villalvilla C, Bianchini R, Bjermer L, Caramori G, et al.
Allergy
. 2023 Dec;
79(5):1089-1122.
PMID: 38108546
The accumulation of senescent cells drives inflammaging and increases morbidity of chronic inflammatory lung diseases. Immune responses are built upon dynamic changes in cell metabolism that supply energy and substrates...
4.
Hellings P, Lau S, Scadding G, Bjermer L, Backer V, Chaker A, et al.
Front Allergy
. 2023 Aug;
4:1236977.
PMID: 37577332
In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of...
5.
Hellings P, Fokkens W, Orlandi R, Adriaensen G, Alobid I, Baroody F, et al.
Rhinology
. 2022 Dec;
61(1):85-89.
PMID: 36507741
Chronic rhinosinusitis (CRS) is known to affect around 5 % of the total population, with major impact on the quality of life of those severely affected (1). Despite a substantial...
6.
Chauhan A, Eriksson G, Storrar W, Brown T, Peterson S, Radner F, et al.
BMC Pulm Med
. 2022 Nov;
22(1):407.
PMID: 36352399
Purpose: Uncontrolled severe asthma constitutes a major economic burden to society. Add-ons to standard inhaled treatments include inexpensive oral corticosteroids and expensive biologics. Nocturnal treatment with Temperature-controlled Laminar Airflow (TLA;...
7.
Chauhan A, Brown T, Storrar W, Bjermer L, Eriksson G, Radner F, et al.
Eur Clin Respir J
. 2021 Mar;
8(1):1894658.
PMID: 33763190
: Allergen avoidance is important in allergic asthma management. Nocturnal treatment with Temperature-controlled Laminar Airflow (TLA) has been shown to provide a significant reduction in the exposure to allergens in...
8.
Maltais F, Naya I, Vogelmeier C, Boucot I, Jones P, Bjermer L, et al.
Respir Res
. 2020 Oct;
21(1):280.
PMID: 33092591
Background: Short-acting β-agonist (SABA) bronchodilators help alleviate symptoms in chronic obstructive pulmonary disease (COPD) and may be a useful marker of symptom severity. This analysis investigated whether SABA use impacts...
9.
Hellings P, Bachert C, Bjermer L, Canonica G, Cardell L, Carney A, et al.
Rhinology
. 2020 Sep;
58(6):618-622.
PMID: 32991658
No abstract available.
10.
Bjermer L, Eriksson G, Radner F, Peterson S, Warner J
Respir Med
. 2019 Feb;
147:19-25.
PMID: 30704694
Background: Allergen avoidance is important in allergic asthma management. Nocturnal treatment with Temperature-controlled Laminar Airflow (TLA; Airsonett) has been shown to provide significant reduction of exposure to allergens in the...